- Report
- August 2026
- 160 Pages
From €2960EUR$3,320USD£2,544GBP
€3700EUR$4,150USD£3,180GBP
- Report
- August 2025
- 150 Pages
Global
From €2817EUR$3,160USD£2,421GBP
€3522EUR$3,950USD£3,026GBP
- Report
- February 2024
- 144 Pages
Global
From €3174EUR$3,560USD£2,728GBP
€3967EUR$4,450USD£3,409GBP
- Report
- June 2025
- 147 Pages
Global
From €3522EUR$3,950USD£3,026GBP
- Report
- January 2024
- 145 Pages
Global
From €3789EUR$4,250USD£3,256GBP
- Report
- May 2025
- 140 Pages
Global
From €3522EUR$3,950USD£3,026GBP
- Report
- February 2024
- 114 Pages
Global
From €3789EUR$4,250USD£3,256GBP
- Report
- April 2026
- 162 Pages
Canada
From €4324EUR$4,850USD£3,716GBP
- Report
- April 2026
- 188 Pages
China
From €4324EUR$4,850USD£3,716GBP
- Report
- April 2026
- 214 Pages
Germany
From €4324EUR$4,850USD£3,716GBP
- Report
- April 2026
- 240 Pages
India
From €4324EUR$4,850USD£3,716GBP
- Report
- March 2026
- 150 Pages
Germany
From €4324EUR$4,850USD£3,716GBP
- Report
- August 2025
- 150 Pages
Global
From €4324EUR$4,850USD£3,716GBP
- Report
- August 2025
- 150 Pages
Global
From €4324EUR$4,850USD£3,716GBP
- Report
- August 2025
- 150 Pages
Global
From €4324EUR$4,850USD£3,716GBP
- Report
- August 2025
- 150 Pages
Global
From €4324EUR$4,850USD£3,716GBP
- Report
- July 2025
- 150 Pages
Global
From €4324EUR$4,850USD£3,716GBP
- Report
- May 2025
- 150 Pages
Global
From €4324EUR$4,850USD£3,716GBP
- Report
- April 2025
- 150 Pages
Global
From €4324EUR$4,850USD£3,716GBP
- Report
- April 2025
- 150 Pages
Global
From €4324EUR$4,850USD£3,716GBP

The Respiratory Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat respiratory diseases. These drugs are used to treat a variety of conditions, including asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis. Commonly prescribed respiratory drugs include bronchodilators, corticosteroids, and antibiotics.
The Respiratory Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Companies in the market include GlaxoSmithKline, AstraZeneca, Merck & Co., Novartis, and Boehringer Ingelheim. These companies are constantly researching and developing new drugs to treat respiratory diseases, as well as improving existing treatments. Show Less Read more